Advertisement
Advertisement

MBX

MBX logo

MBX Biosciences, Inc. Common Stock

10.37
USD
-0.35
-3.26%
Jun 13, 15:59 UTC -4
Closed
exchange

After-Market

10.36

-0.01
-0.09%

MBX Biosciences, Inc. Common Stock Profile

About

MBX Biosciences Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company's pipeline includes its lead product candidate MBX 2109, MBX 1416 and MBX 4291. MBX Biosciences Inc. is based in CARMEL, Ind.

Info & Links

CEO

P. Kent Hawryluk

Headquarters

11711 N. Meridian Street, Suite 300
Carmel, IN 46032, UNITED STATES

Sector

Medical

Auditor

Ernst & Young LLP

Share holders

71

Employees

43

MBX Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

346.31M

Enterprise Value

316.41M

Enterprise Value/EBITDA(ttm)

-6.87

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-16.83%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-46.06M

Net Income Available to Common(ttm)

-42.02M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

33.42M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

240.79M

Total Cash Per Share(mrq)

7.20

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

23.31%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

7.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.68

Free Cash Flow(ytd)

-22.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement